We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Bacterial Curli Fibers Reverse Symptoms of Inflammatory Bowel Disease in Mouse Model

By LabMedica International staff writers
Posted on 11 Nov 2015
Print article
Image: Topographical images of colonies of (A) curli non-producing and (B) curli- producing strains of E. coli grown on agar for 48 hours at 28 degrees Celsius (Photo courtesy of the [US] Department of Agriculture).
Image: Topographical images of colonies of (A) curli non-producing and (B) curli- producing strains of E. coli grown on agar for 48 hours at 28 degrees Celsius (Photo courtesy of the [US] Department of Agriculture).
A novel treatment for inflammatory bowel disease based on oral administration of a single dose of purified curli fibers was successfully tested in a mouse model of acute colitis.

Curli are the major protein components of a complex extra-cellular matrix produced by many Enterobacteriaceae. Curli fibers, which share many distinguishing biochemical and structural properties with eukaryotic amyloid fibers, are involved in adhesion to surfaces, cell aggregation, and biofilm formation. Curli also mediate host cell adhesion and invasion, and they are potent inducers of the host inflammatory response.

The structure and biogenesis of curli are unique among bacterial fibers that have been described to date. Structurally and biochemically, curli fibers belong to a growing class of fibrous proteins known as amyloids. Amyloid fiber formation is responsible for several human diseases including Alzheimer's, Huntington's, and prion diseases, although the process of in vivo amyloid formation is not well understood.

Recognition of curli fibers by the Toll-like receptor (TLR)2/1 complex was found to reinforce the membranes lining the bowel, which might counter damage induced by inflammatory bowel disease. To evaluate the therapeutic potential of curli fibers, investigators at Temple University (Philadelphia, PA, USA) studied the effect of purified curli fibers on inflammation in a mouse model of acute colitis.

In the study bone marrow–derived macrophages as well as lamina propria cells were treated with curli fibers of both pathogenic Salmonella enterica serovar Typhimurium and commensal Escherichia coli Nissle 1917 biofilms. In an in vivo experiment, mice were given 0.1 or 0.4 milligrams of purified curli orally one day post administration of 1% 2,4,6-trinitrobenzene sulfonic acid (TNBS) enema. Histopathological analysis was performed on distal colonic tissue taken six days post TNBS enema. RNA extracted from colonic tissue was subjected to RT (real time)-PCR.

Results published in the October 14, 2015, online edition of the journal Biofilms and Microbiomes revealed that curli fibers of both pathogenic and commensal bacteria were recognized by TLR2 leading to the production of IL-10 (interleukin-10), an immunomodulatory cytokine of intestinal homeostasis. Treatment of mice with a single dose of curli increased transcript levels of IL-10 in the colon and ameliorated the disease pathology in TNBS-induced colitis. Curli treatment was comparable to the treatment with anti-tumor necrosis factor alpha (anti-TNFalpha) antibodies, a treatment known to reduce the severity of acute colitis in humans and mice.

"The really remarkable finding is that one dose of curli—not a daily dose, but just a single oral dose—decreased inflammation and disease pathology and altered the cytokine profile," said senior author Dr. Çagla Tükel, assistant professor of microbiology and immunology at Temple University.

Related Links:
Temple University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.